There is a need to encourage pharmaceutical manufacturers to make pharmaceutical products available at heavily reduced prices in significantly increased volumes by ensuring through this Regulation that such products remain on the poorest developing country markets.
Tá gá le monaróirí cógaisíochta a spreagadh chun méideanna atá méadaithe go mór de tháirgí cógaisíochta a sholáthar ar phraghsanna atá laghdaithe go mór trína áirithiú leis an Rialachán seo go bhfanann táirgí den sórt sin ar mhargaí sna tíortha is boichte atá i mbéal forbartha.